|
1
|
Lilja H, Ulmert D and Vickers AJ:
Prostate-specific antigen and prostate cancer: Prediction,
detection and monitoring. Nat Rev Cancer. 8:268–278. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Crawford ED: Epidemiology of prostate
cancer. Urology. 62 6 Suppl 1:S3–S12. 2003. View Article : Google Scholar
|
|
3
|
Zhu Y, Yang XQ, Han CT, Dai B, Zhang HL,
Shi GH, Wang CF and Ye DW: Pathological features of localized
prostate cancer in China: A contemporary analysis of radical
prostatectomy specimens. PLoS One. 10:e01210762015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hellerstedt BA and Pienta KJ: The current
state of hormonal therapy for prostate cancer. CA Cancer J Clin.
52:154–179. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tsai M-C, Spitale RC and Chang HY: Long
intergenic noncoding RNAs: New links in cancer progression. Cancer
Res. 71:3–7. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Geisler S and Coller J: RNA in unexpected
places: Long non-coding RNA functions in diverse cellular contexts.
Nat Rev Mol Cell Biol. 14:699–712. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zeng C, Xu Y, Xu L, Yu X, Cheng J, Yang L,
Chen S and Li Y: Inhibition of long non-coding RNA NEAT1 impairs
myeloid differentiation in acute promyelocytic leukemia cells. BMC
Cancer. 14:6932014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gibb EA, Brown CJ and Lam WL: The
functional role of long non-coding RNA in human carcinomas. Mol
Cancer. 10:38. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Luo X, Yang W, Ye DQ, Cui H, Zhang Y,
Hirankarn N, Qian X, Tang Y, Lau YL, de Vries N, et al: A
functional variant in microRNA-146a promoter modulates its
expression and confers disease risk for systemic lupus
erythematosus. PLoS Genet. 7:e10021282011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ding J, Li D, Gong M, Wang J, Huang X, Wu
T and Wang C: Expression and clinical significance of the long
non-coding RNA PVT1 in human gastric cancer. Onco Targets Ther.
7:1625–1630. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ding C, Yang Z, Lv Z, Du C, Xiao H, Peng
C, Cheng S, Xie H, Zhou L, Wu J and Zheng S: Long non-coding RNA
PVT1 is associated with tumor progression and predicts recurrence
in hepatocellular carcinoma patients. Oncol Lett. 9:955–963. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Barsotti AM, Beckerman R, Laptenko O,
Huppi K, Caplen NJ and Prives C: p53-dependent Induction of PVT1
and miR-1204. J Biol Chem. 287:2509–2519. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chapman MH, Tidswell R, Dooley JS,
Sandanayake NS, Cerec V, Deheragoda M, Lee AJ, Swanton C, Andreola
F and Pereira SP: Whole genome RNA expression profiling of
endoscopic biliary brushings provides data suitable for biomarker
discovery in cholangiocarcinoma. J Hepatol. 56:877–885. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li Q, Dai Y, Wang F and Hou S:
Differentially expressed long non-coding RNAs and the prognostic
potential in colorectal cancer. Neoplasma. 63:977–983. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang XW, Bu P, Liu L, Zhang Xz and Li J:
Overexpression of long non-coding RNA PVT1 in gastric cancer cells
promotes the development of multidrug resistance. Biochem Biophys
Res Commun. 462:227–232. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ilboudo A, Chouhan J, McNeil BK, Osborne
JR and Ogunwobi OO: PVT1 Exon 9: A potential biomarker of
aggressive prostate cancer? Int J Environ Res Public Health.
13:ijerph13010012. 2016.
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lei B, Zhou X, Lv D, Wan B, Wu H, Zhong L,
Shu F and Mao X: Apoptotic and nonapoptotic function of caspase 7
in spermatogenesis. Asian J Androl. 719:47–51. 2007.
|
|
20
|
Yang YR, Zang SZ, Zhong CL, Li YX, Zhao SS
and Feng XJ: Increased expression of the lncRNA PVT1 promotes
tumorigenesis in non-small cell lung cancer. Int J Clin Exp Pathol.
7:6929–6935. 2014.PubMed/NCBI
|
|
21
|
Wan L, Sun M, Liu GJ, Wei CC, Zhang EB,
Kong R, Xu TP, Huang MD and Wang ZX: Long noncoding RNA PVT1
Promotes promotes non-small cell lung cancer cell proliferation
through epigenetically regulating LATS2 expression. Mol Cancer
Ther. 15:1082–1094. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yuan CL, Li H, Zhu L, Liu Z, Zhou J and
Shu Y: Aberrant expression of long noncoding RNA PVT1 and its
diagnostic and prognostic significance in patients with gastric
cancer. Neoplasma. 63:442–449. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cao WJ, Wu HL, He BS, Zhang YS and Zhang
ZY: Analysis of long non-coding RNA expression profiles in gastric
cancer. World J Gastroenterol. 19:3658–3664. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu Y, Wang YQ, Weng WW, Zhang QY, Yang XQ,
Gan HL, Yang YS, Zhang PP, Sun MH, Xu MD and Wang CF: A
serum-circulating long noncoding RNA signature can discriminate
between patients with clear cell renal cell carcinoma and healthy
controls. Oncogenesis. 5:e1922016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang S, Zhang G and Liu J: Long noncoding
RNA PVT1 promotes cervical cancer progression through
epigenetically silencing miR-200b. APMIS. 124:649–658. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhuang C, Li J, Liu Y, Chen M, Yuan J, Fu
X, Zhan Y, Liu L, Lin J, Zhou Q, et al: Tetracycline-inducible
shRNA targeting long non-coding RNA PVT1 inhibits cell growth and
induces apoptosis in bladder cancer cells. Oncotarget.
6:41194–41203. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yan H, Yang Y, Zhang L, Tang G, Wang Y,
Xue G, Zhou W and Sun S: Characterization of the genotype and
integration patterns of hepatitis B virus in early- and late-onset
hepatocellular carcinoma. Hepatology. 61:1821–1831. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu E, Liu Z, Zhou Y, Mi R and Wang D:
Overexpression of long non-coding RNA PVT1 in ovarian cancer cells
promotes cisplatin resistance by regulating apoptotic pathways. Int
J Clin Exp Med. 8:20565–20572. 2015.PubMed/NCBI
|
|
29
|
Zeng C, Yu X, Lai J, Yang L, Chen S and Li
Y: Overexpression of the long non-coding RNA PVT1 is correlated
with leukemic cell proliferation in acute promyelocytic leukemia. J
Hematol Oncol. 8:1262015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Takahashi Y, Sawada G, Kurashige J, Uchi
R, Matsumura T, Ueo H, Takano Y, Eguchi H, Sudo T, Sugimachi K, et
al: Amplification of PVT-1 is involved in poor prognosis via
apoptosis inhibition in colorectal cancers. Br J Cancer.
110:164–171. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bawa P, Zackaria S, Verma M, Gupta S,
Srivatsan R, Chaudhary B and Srinivasan S: Integrative analysis of
normal long intergenic non-coding rnas in prostate cancer. PLoS
One. 10:e01221432015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yu J, Han J, Zhang J, Li G, Liu H, Cui X,
Xu Y, Li T, Liu J and Wang C: The long noncoding RNAs PVT1 and
uc002mbe.2 in sera provide a new supplementary method for
hepatocellular carcinoma diagnosis. Medicine (Baltimore).
95:e44362016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang F, Yuan JH, Wang SB, Yang F, Yuan SX,
Ye C, Yang N, Zhou WP, Li WL, Li W and Sun SH: Oncofetal long
noncoding RNA PVT1 promotes proliferation and stem cell-like
property of hepatocellular carcinoma cells by stabilizing NOP2.
Hepatology. 60:1278–1290. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cui D, Yu CH, Liu M, Xia QQ, Zhang YF and
Jiang WL: Long non-coding RNA PVT1 as a novel biomarker for
diagnosis and prognosis of non-small cell lung cancer. Tumour Biol.
37:4127–4134. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Guan Y, Kuo WL, Stilwell JL, Takano H,
Lapuk AV, Fridlyand J, Mao JH, Yu M, Miller MA, Santos JL, et al:
Amplification of PVT1 contributes to the pathophysiology of ovarian
and breast cancer. Clin Cancer Res. 13:5745–5755. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kong R, Zhang EB, Yin DD, You LH, Xu TP,
Chen WM, Xia R, Wan L, Sun M, Wang ZX, et al: Long noncoding RNA
PVT1 indicates a poor prognosis of gastric cancer and promotes cell
proliferation through epigenetically regulating p15 and p16. Mol
Cancer. 14:822015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tseng YY, Moriarity BS, Gong W, Akiyama R,
Tiwari A, Kawakami H, Ronning P, Reuland B, Guenther K, Beadnell
TC, et al: PVT1 dependence in cancer with MYC copy-number increase.
Nature. 512:82–86. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xia P, Zhang R and Ge G: C/EBPβ mediates
tnf-α-induced cancer cell migration by inducing mmp expression
dependent on p38 MAPK. J Cell Biochem. 116:2766–2777. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cheng G, Gao F, Sun X, Bi H and Zhu Y:
Paris saponin VII suppresses osteosarcoma cell migration and
invasion by inhibiting MMP-2/9 production via the p38 MAPK
signaling pathway. Mol Med Rep. 14:3199–3205. 2016. View Article : Google Scholar : PubMed/NCBI
|
